I was thinking that a fund raising before the approval,but now we got 2 approval in bag and I am sure they don’t do any fund raise in near future,They renewed the 3 million shares shelf stock in April as a precaution incase any adverse effect come from FDA.But everything good now and company valued near to a billion and enough cash to run upto vitiligo 2025 expansion as of CEO updates.The shelf renewed stock is a back up and anytime they can cancel it according to the notes.
SP if both FDA approvals go through, page-232
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.50 |
Change
0.120(5.04%) |
Mkt cap ! $170.2M | |||
| Open | High | Low | Value | Volume |
| $2.44 | $2.50 | $2.43 | $499.6K | 203.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1658 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.50 | 4025 | 3 |
View Market Depth
| Last trade - 13.45pm 09/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |